Age-related biological features of germ cell tumors

Genes Chromosomes and Cancer

Volumn 53, Issue 3, 2014, Pages 215-227

  Collinson, Kate ^a   Murray, Matthew J ^b   Orsi, Nicolas M ^a   Cummings, Michele ^a   Shipley, Janet ^c   Joffe, Johnathan K ^d   Coleman, Nicholas ^b   Stark, Daniel ^a  

^a ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^d CALDERDALE AND HUDDERSFIELD NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL FACTOR; CISPLATIN; MICRORNA;

AGE DISTRIBUTION; ARTICLE; CHROMOSOME ABERRATION; GENE EXPRESSION; GENETIC SUSCEPTIBILITY; GENOME IMPRINTING; GERM CELL TUMOR; HUMAN; PEDIATRICS; PRIORITY JOURNAL; SEX DIFFERENCE;

ADOLESCENT; ADULT; AGE FACTORS; CHILD; CHROMOSOME ABERRATIONS; GENETIC LOCI; GENETIC PREDISPOSITION TO DISEASE; GENOMIC IMPRINTING; HUMANS; MICRORNAS; NEOPLASM INVASIVENESS; NEOPLASMS, GERM CELL AND EMBRYONAL; OPEN READING FRAMES; RNA, MESSENGER; YOUNG ADULT;

EID: 84892480362     PISSN: 10452257     EISSN: 10982264     Source Type: Journal    
DOI: 10.1002/gcc.22131     Document Type: Article

References (84)

1. Almstrup K, Hoei-Hansen CE, Wirkner U, Blake J, Schwager C, Ansorge W, Nielsen JE, Skakkebaek NE, Rajpert-De Meyts E, Leffers H. 2004. Embryonic stem cell-like features of testicular carcinoma in situ revealed by genome-wide gene expression profiling. Cancer Res 64:4736-4743.
2. Atkin NB, Baker MC. 1982. Specific chromosome change, i(12p), in testicular tumours? Lancet 2:1349.
3. Atkin NB, Baker MC. 1987. Abnormal chromosomes including small metacentrics in 14 ovarian cancers. Cancer Genet Cytogenet 26:355-361.
4. Boissel N, Auclerc M, Lhéritier V, Perel Y, Thomas X, Leblanc T, Rousselot P, Cayuela J, Gabert J, Fegueux N, Piguet C, Huguet-Rigal F, Berthou C, Boiron J, Pautas C, Michel G, Fière D, Leverger G, Dombret H, Baruchel A. 2003. Should adolescents with acute lymphoblastic leukemia be treated as old children or young adults? Comparison of the French FRALLE-93 and LALA-94 trials. J Clin Oncol 21:774-780.
5. Bokemeyer C, Köhrmann O, Tischler J, Weißbach L, Räth U, Haupt A, Schöffski P, Harstrick A, Schmoll H-J. 1996. A randomised trial of cisplatin, etoposide and bleomycin (PEB) versus carboplatin, etoposide and bleomycin (CEB) for patients with 'good risk' metastatic non-seminomatous germ cell tumours. Ann Oncol 7:1015-1021.
6. Bussey KJ, Lawce HJ, Olson SB, Arthur DC, Kalousek DK, Krailo M, Giller R, Heifetz S, Womer R, Magenis RE. 1999. Chromosome abnormalities of eighty-one pediatric germ cell tumors: Sex, age, site, and histopathology related differences a Children's Cancer Group study. Genes Chromosomes Cancer 25:134-146.
7. Bussey KJ, Lawce HJ, Himoe E, Shu XO, Suijkerbuijk RF, Olson SB, Magenis RE. 2001. Chromosomes 1 and 12 abnormalities in pediatric germ cell tumors by interphase fluorescence in situ hybridization. Cancer Genet Cytogenet 125:112-118.
8. Cossu-Rocca P, Zhang S, Roth LM, Eble JN, Zheng W, Karim FW, Michael H, Emerson RE, Jones TD, Hattab EM, Cheng L. 2006. Chromosome 12p abnormalities in dysgerminoma of the ovary: A FISH analysis. Mod Pathol 19:611-615.
9. Dal Cin P, Dei Tos AP, Qi H, Giannini C, Furlanetto A, Longatti PL, Marynen P, Van den Berghe H. 1998. Immature teratoma of the pineal gland with isochromosome 12p. Acta Neuropathol (Berl) 95:107-110.
10. Dieckmann KP, Skakkebaek NE. 1999. Carcinoma In situ of the testis: Review of biological and clinical features. Int J Cancer 83:815-822.
11. Fan R, Ulbright T. 2012. Does intratubular germ cell neoplasia, unclassified type exist in prepubertal, cryptorchid testes? Fetal Pediatr Pathol 31:21-24.
12. Furukawa S, Haruta M, Arai Y, Honda S, Ohshima J, Sugawara W, Kageyama Y, Higashi Y, Nishida K, Tsunematsu Y, Nakadate H, Ishii M, Kaneko Y. 2009. Yolk sac tumor but not seminoma or teratoma is associated with abnormal epigenetic reprogramming pathway and shows frequent hypermethylation of various tumor suppressor genes. Cancer Sci. 100;698-708.
13. Gilbert D, Rapley E, Shipley J. 2011. Testicular germ cell tumours: Predisposition genes and the male germ cell niche. Nat Rev Cancer 11:278-288.
14. Gillis AJM, Stoop HJ, Hersmus R, Oosterhuis JW, Sun Y, Chen C, Guenther S, Sherlock J, Veltman I, Baeten J, van der Spek PJ, de Alarcon P, Looijenga LHJ. 2007. High-throughput microRNAome analysis in human germ cell tumours. J Pathol 213:319-328.
15. Giwercman A, Skakkebaek N. 1993. Carcinoma in situ of the testis: Biology, screening and management. Eur Urol 23:19-21.
16. Giwercman A, Müller J, Skakkebaek NE. 1991. Prevalence of carcinoma in situ and other histopathological abnormalities in testes from 399 men who died suddenly and unexpectedly. J Urol 145:77-80.
17. Hale GA, Marina NM, Jones-Wallace D, Greenwald CA, Jenkins JJ, Rao BN, Luo X, Hudson MM. 1999. Late effects of treatment for germ cell tumors during childhood and adolescence. J Pediatr Hematol Oncol 21:115-22.
18. Hale J, Olson T, Nicholson J, Dang H, Krailo M, Billmire D, Donachie P, Thornton C, Rodriguez-Galindo C, Frazier A. 2012. Carboplatin (CBP) versus cisplatin (CP) within prognostic groups in pediatric extracranial malignant germ cell tumors (MGCTs). In: ASCO Annual Meeting, Chicago, IL, May 31, June 3.
19. Hawkins E, Heifetz SA, Giller R, Cushing B. 1997. The prepubertal testis (prenatal and postnatal): Its relationship to intratubular germ cell neoplasia: A combined pediatric oncology group and children's cancer study group. Hum Pathol 28:404-409.
20. Honorio S, Agathanggelou A, Wernert N, Rothe M, Maher ER, Latif F. 2003. Frequent epigenetic inactivation of the RASSF1A tumour suppressor gene in testicular tumours and distinct methylation profiles of seminoma and nonseminoma testicular germ cell tumours. Oncogene 23;22:461-466.
21. Horwich A, Sleijfer DT, Fossa SD, Kaye SB, Oliver RT, Cullen MH, Mead GM, de Wit R, de Mulder PH, Dearnaley DP, Cook PA, Sylvester RJ, Stenning SP. 1997. Randomized trial of bleomycin, etoposide, and cisplatin compared with bleomycin, etoposide, and carboplatin in good-prognosis metastatic nonseminomatous germ cell cancer: A Multiinstitutional Medical Research Council European Organization for Research and Treatment of Cancer Trial. J Clin Oncol 15:1844-1852.
22. Horwich A, Shipley J, Huddart R. 2006. Testicular germ-cell cancer. Lancet 367:754-765.
23. Hu LM, Phillipson J, Barsky SH. 1992. Intratubular germ cell neoplasia in infantile yolk sac tumor verification by tandem repeat sequence in situ hybridization. Diagn Mol Pathol 1.
24. Huyghe E, Soulie M, Escourrou G, Mieusset R, Plante P, Thonneau P. 2005. Conservative managment of small testicular tumour relative to carcinoma in situ prevalence. J Urol 173:820-823.
25. Ichikawa M, Arai Y, Haruta M, Furukawa S, Ariga T, Kajii T, Kaneko Y. 2013. Meiosis error and subsequent genetic and epigenetic alterations invoke the malignant transformation of germ cell tumor. Genes Chromosomes Cancer 52:274-286.
26. Jacobsen GK, Henriksen OB, von der Maase H. 1981. Carcinoma in situ of testicular tissue adjacent to malignant germ-cell tumors: A study of 105 cases. Cancer Genet Cytogenet 47:2660-2662.
27. Jenkyn DJ, McCartney AJ. 1987. A chromosome study of three ovarian tumors. Cancer Genet Cytogenet 26:327-337.
28. Jeyapalan JN, Noor DA, Lee SH, Tan CL, Appleby VA, Kilday JP, Palmer RD, Schwalbe EC, Clifford SC, Walker DA, Murray MJ, Coleman N, Nicholson JC, Scotting PJ. 2011. Methylator phenotype of malignant germ cell tumours in children identifies strong candidates for chemotherapy resistance. Br J Cancer 9;105:575-585.
29. Jorgensen N, Muller J, Giwercman A, Visfeldt J, Møller H, Skakkebaek N. 1995. DNA content and expression of tumour markers in germ cells adjacent to germ cell tumours in childhood: Probably a different origin for infantile and adolescent germ cell tumours. J Pathol 176:269-278.
30. Kanetsky PA, Mitra N, Vardhanabhuti S, Li M, Vaughn DJ, Letrero R, Ciosek SL, Doody DR, Smith LM, Weaver J, Albano A, Chen C, Starr JR, Rader DJ, Godwin AK, Reilly MP, Hakonarson H, Schwartz SM, Nathanson KL. 2009. Common variation in KITLG and at 5q31.3 proximate to SPRY4 predispose to testicular germ cell cancer. Nat Genet 41:811-815.
31. Kato N, Tamura G, Fukase M, Shibuya H, Motoyama T. 2003. Hypermethylation of the RUNX3 gene promoter in testicular yolk sac tumor of infants. Am J Pathol 163;387-391.
32. Korkola JE, Houldsworth J, Feldman DR, Olshen AB, Qin LX, Patil S, Reuter VE, Bosl GJ, Chaganti RS. 2009. Identification and validation of a gene expression signature that predicts outcome in adult men with germ cell tumors. J Clin Oncol 27:5240-5247.
33. Koul S, McKiernan JM, Narayan G, Houldsworth J, Bacik J, Dobrzynski DL, Assaad AM, Mansukhani M, Reuter VE, Bosl GJ, Chaganti RS, Murty VV. 2004. Role of promoter hypermethylation in Cisplatin treatment response of male germ cell tumors. Mol Cancer 3:16.
34. Kraggerud SM, Szymanska J, Abeler VM, Kaern J, Eknaes M, Heim S, Teixeira MR, Trope CG, Peltomaki P, Lothe RA. 2000. DNA copy number changes in malignant ovarian germ cell tumors. Cancer Res 60:3025-3030.
35. Kraggerud SM, Skotheim RI, Szymanska J, Eknæs M, Fosså SD, Stenwig AE, Peltomäki P, Lothe RA. 2002. Genome profiles of familial/bilateral and sporadic testicular germ cell tumors. Genes Chromosomes Cancer 34:168-174.
36. Krege S, Beyer J, Souchon R, Albers P, Albrecht W, Algaba F, Bamberg M, Bodrogi I, Bokemeyer C, Cavallin-Ståhl E, Classen J, Clemm C, Cohn-Cedermark G, Culine S, Daugaard G, De Mulder PH, De Santis M, de Wit M, de Wit R, Derigs HG, Dieckmann KP, Dieing A, Droz JP, Fenner M, Fizazi K, Flechon A, Fosså SD, del Muro XG, Gauler T, Geczi L, Gerl A, Germa-Lluch JR, Gillessen S, Hartmann JT, Hartmann M, Heidenreich A, Hoeltl W, Horwich A, Huddart R, Jewett M, Joffe J, Jones WG, Kisbenedek L, Klepp O, Kliesch S, Koehrmann KU, Kollmannsberger C, Kuczyk M, Laguna P, Galvis OL, Loy V, Mason MD, Mead GM, Mueller R, Nichols C, Nicolai N, Oliver T, Ondrus D, Oosterhof GO, Ares LP, Pizzocaro G, Pont J, Pottek T, Powles T, Rick O, Rosti G, Salvioni R, Scheiderbauer J, Schmelz HU, Schmidberger H, Schmoll HJ, Schrader M, Sedlmayer F, Skakkebaek NE, Sohaib A, Tjulandin S, Warde P, Weinknecht S, Weissbach L, Wittekind C, Winter E, Wood L, H vdM. 2008. European Consensus Conference on Diagnosis and Treatment of Germ Cell Cancer: A Report of the Second Meeting of the European Germ Cell Cancer Consensus group (EGCCCG): Part I. Eur Urol 53:478-496.
37. Looijenga L, Stoop H, Hersmus R, Gillis A, Wolter Oosterhuis J. 2007. Genomic and expression profiling of human spermatocytic seminomas: Pathogenetic implications. Int J Androl 30:328-336.
38. Looijenga LH, Gillis AJ, Van Putten WL, Oosterhuis JW. 1993. In situ numeric analysis of centromeric regions of chromosomes 1, 12, and 15 of seminomas, nonseminomatous germ cell tumors, and carcinoma in situ of human testis. Lab Invest 68:211-219.
39. Looijenga LH, Oosterhuis JW. 1999. Pathogenesis of testicular germ cell tumours. Rev Reprod 4:90-100.
40. Looijenga LH, Rosenberg C, van Gurp R, Geelen E, van Echten-Arends J, de Jong B, Mostert M, Wolter Oosterhuis J. 2000. Comparative genomic hybridization of microdissected samples from different stages in the development of a seminoma and a non-seminoma. J Pathol 191:187-192.
41. Maase Hvd, Rørth M, Walbom-Jørgensen S, Sørensen B, Christophersen I, Hald T, Jacobsen G, Berthelsen J, Skakkebaek N. 1986. Carcinoma in situ of contralateral testis in patients with testicular germ cell cancer: Study of 27 cases in 500 patients. Br Med J 293:1398-1401.
42. Manivel JC, Simonton S, Wold LE, Dehner LP. 1988. Absence of intratubular germ cell neoplasia in testicular yolk sac tumors in children. A histochemical and immunohistochemical study. Arch Pathol Lab Med 112:641-645.
43. Manivel JC, Reinberg Y, Niehans GA, Fraley EE. 1989. Intratubular germ cell neoplasia in testicular teratomas and epidermoid cysts. Correlation with prognosis and possible biologic significance. Cancer 64:715-720.
44. Mann J, Pearson D, Barrett A, Raafat F, Barnes J, Wallendszus K. 1989. Results of the United Kingdom Children's Cancer Study Group's malignant germ cell tumor studies. Cancer 63:1657-1667.
45. Mann JR, Raafat F, Robinson K, Imeson J, Gornall P, Sokal M, Gray E, McKeever P, Hale J, Bailey S, Oakhill A. 2000. The United Kingdom Children's Cancer Study Group's second germ cell tumor study: Carboplatin, etoposide, and bleomycin are effective treatment for children with malignant extracranial germ cell tumors, with acceptable toxicity. J Clin Oncol 18:3809-3818.
46. Marina N, London WB, Frazier AL, Lauer S, Rescorla F, Cushing B, Malogolowkin MH, Castleberry RP, Womer RB, Olson T. 2006. Prognostic factors in children with extragonadal malignant germ cell tumors: A Pediatric Intergroup Study. J Clin Oncol 24:2544-2548.
47. McKenney JK, Heerema-McKenney A, Rouse RV. 2007. Extragonadal germ cell tumors: A review with emphasis on pathologic features, clinical prognostic variables, and differential diagnostic considerations. Adv Anat Pathol 14:69-92.
48. Murray M, Fern L, Stark D, Eden T, Nicholson J. 2009. Breaking down barriers: Improving outcomes for teenagers and young adults with germ cell tumours. Oncol Rev 3:201-206.
49. Nicholson J, Palmer R. 2010. Germ Cell Tumours. in Pediatric Hematology and Oncology (eds E. J. Estlin, R. J. Gilbertson and R. F. Wynn), Wiley-Blackwell, Oxford, UK.
50. Nonomura N, Miki T, Nishimura K, Kanno N, Kojima Y, Okuyama A. 1997. Altered imprinting of the H19 and insulin-like growth factor II genes in testicular tumors. J Urol 157:1977-1979.
51. Oosterhuis JW, Looijenga LH. 2005. Testicular germ-cell tumours in a broader perspective. Nat Rev Cancer 5:210-222.
52. Oosterhuis JW, Looijenga LHJ, van Echten J, de Jong B. 1997. Chromosomal constitution and developmental potential of human germ cell tumors and teratomas. Cancer Genet Cytogenet 95:96-102.
53. Ottesen AM, Kirchhoff M, De-Meyts ER, Maahr J, Gerdes T, Rose H, Lundsteen C, Petersen PM, Philip J, Skakkebæk NE. 1997. Detection of chromosomal aberrations in seminomatous germ cell tumours using comparative genomic hybridization. Genes Chromosomes Cancer 20:412-418.
54. Ottesen AM, Skakkebæk NE, Lundsteen C, Leffers H, Larsen J, Rajpert-De Meyts E. 2003. High-resolution comparative genomic hybridization detects extra chromosome arm 12p material in most cases of carcinoma in situ adjacent to overt germ cell tumors, but not before the invasive tumor development. Genes Chromosomes Cancer 38:117-125.
55. Palmer RD, Foster NA, Vowler SL, Roberts I, Thornton CM, Hale JP, Schneider DT, Nicholson JC, Coleman N. 2007. Malignant germ cell tumours of childhood: New associations of genomic imbalance. Br J Cancer 96:667-676.
56. Palmer RD, Barbosa-Morais NL, Gooding EL, Muralidhar B, Thornton CM, Pett MR, Roberts I, Schneider DT, Thorne N, Tavare S, Nicholson JC, Coleman N. 2008. Pediatric malignant germ cell tumors show characteristic transcriptome profiles. Cancer Res 68:4239-4247.
57. Palmer RD, Murray MJ, Saini HK, van Dongen S, Abreu-Goodger C, Muralidhar B, Pett MR, Thornton CM, Nicholson JC, Enright AJ, Coleman N. 2010. Malignant germ cell tumors display common microRNA profiles resulting in global changes in expression of messenger RNA targets. Cancer Res 70:2911-2923.
58. Perlman E, Hu J, Ho D, Cushing B, Lauer S, Castleberry R. 2000. Genetic analysis of childhood endodermal sinus tumors by comparative genomic hybridization. J Pediatr Hematol Oncol 22:100-105.
59. Poynter JN, Hooten AJ, Frazier AL, Ross JA. 2012. Associations between variants in KITLG, SPRY4, BAK1, and DMRT1 and pediatric germ cell tumors. Genes Chromosomes Cancer 51:266-271.
60. Rajpert-De Meyts E. 2006. Developmental model for the pathogenesis of testicular carcinoma in situ: Genetic and environmental aspects. Hum Reprod Update 12:303-323.
61. Rapley EA, Turnbull C, Olama AAA, Dermitzakis ET, Linger R, Huddart RA, Renwick A, Hughes D, Hines S, Seal S, Morrison J, Nsengimana J, Deloukas P, Rahman N, Bishop DT, Easton DF, Stratton MR. 2009. A genome-wide association study of testicular germ cell tumor. Nat Genet 41:807-810.
62. Renedo DE, Trainer TD. 1994. Intratubular germ cell neoplasia (ITGCN) with p53 and PCNA expression and adjacent mature teratoma in an infant testis. An immunohistochemical and morphologic study with a review of the literature. Am J Surg Pathol 18:947-952.
63. Riopel MA, Spellerberg A, Griffin CA, Perlman EJ. 1998. Genetic analysis of ovarian germ cell tumors by comparative genomic hybridization. Cancer Res 58:3105-3110.
64. Rodriguez E, Melamed J, Reuter V, Chaganti RS. 1995. Chromosome 12 abnormalities in malignant ovarian germ cell tumors. Cancer Genet Cytogenet 82:62-66.
65. Rosenberg C, van Gurp R, Geelen E, Oosterhuis J, Looijenga L. 2000. Overrepresentation of the short arm of chromosome 12 is related to invasive growth of human testicular seminomas and nonseminomas. Oncogene 19:5858-5862.
66. Ross JA, Schmidt PT, Perentesis JP, Davies SM. 1999. Genomic imprinting of H19 and insulin-like growth factor-2 in pediatric germ cell tumors. Cancer Genet Cytogenet 8:1389-1394.
67. Schneider DT, Schuster AE, Fritsch MK, Hu J, Olson T, Lauer S, Gobel U, Perlman EJ. 2001. Multipoint imprinting analysis indicates a common precursor cell for gonadal and nongonadal pediatric germ cell tumors. Cancer Res 61:7268-7276.
68. Schneider DT, Schuster AE, Fritsch MK, Calaminus G, Göbel U, Harms D, Lauer S, Olson T, Perlman EJ. 2002. Genetic analysis of mediastinal nonseminomatous germ cell tumors in children and adolescents. Genes Chromosomes Cancer 34:115-125.
69. Shenouda S, Alahari S. 2009. MicroRNA function in cancer: Oncogene or a tumor suppressor? Cancer Metastasis Rev 28:369-378.
70. Skakkebaek N. 1978. Carcinomas in situ of the testis: Frequency and relationship to invasive germ cell tumours in infertile men. Histopathology 2:157-170.
71. Skakkebaek NE. 1972. Possible carcinoma-in-situ of the testis. Lancet 2:516-517.
72. Speleman F, De Potter C, Dal Cin P, Kathelijne. M, Herwig. I, Genevieve. L, Yves. B, Jules. L, Herman. VDB. 1990. i(12p) in a malignant ovarian tumor. Cancer Genet Cytogenet 45:49-53.
73. Speleman F, Laureys G, Benoit Y, Cuvelier C. 1992. i(12p) in a near-diploid mature ovarian teratoma. Cancer Genet Cytogenet 60:216-218.
74. Stamp IM, Barlebo H, Rix M, Jacobsen GK. 1993. Intratubular germ cell neoplasia in an infantile testis with immature teratoma. Histopathology 22:69-72.
75. Stern JW, Bunin N. 2002. Prospective study of carboplatin-based chemotherapy for pediatric germ cell tumors. Med Pediatr Oncol 39:163-167.
76. Summersgill B, Goker H, Weber-Hall S, Huddart R, Horwich A, Shipley J. 1998. Molecular cytogenetic analysis of adult testicular germ cell tumours and identification of regions of consensus copy number change. Br J Cancer 77:305-313.
77. Summersgill B, Osin P, Lu Y, Huddart R, Shipley J. 2001. Chromosomal imbalances associated with carcinoma in situ and associated testicular germ cell tumours of adolescents and adults. Br J Cancer 85:213-220.
78. Surti U, Hoffner L, Chakravarti A, Ferrell RE. 1990. Genetics and biology of human ovarian teratomas. Cytogenetic analysis and mechanism of origin. Am J Hum Genet 47:635-643.
79. Teilum G. 1965. Classification of endodermal sinus tumour (mesoblatoma vitellinum) and so-called "embryonal carcinoma" of the ovary. Acta Pathol Microbiol Scand 64:407-429.
80. Turnbull C, Rapley EA, Seal S, Pernet D, Renwick A, Hughes D, Ricketts M, Linger R, Nsengimana J, Deloukas P, Huddart RA, Bishop DT, Easton DF, Stratton MR, Rahman N. 2010. Variants near DMRT1, TERT and ATF7IP are associated with testicular germ cell cancer. Nat Genetics 42:604-607.
81. van Echten J, Oosterhuis JW, Looijenga LHJ, van de Pol M, Wiersema J, Meerman GJT, Koops HS, Sleijfer DT, Jong BD. 1995. No recurrent structural abnormalities apart from i(12p) in primary germ cell tumors of the adult testis. Genes Chromosomes Cancer 14:133-144.
82. van Gurp R, Oosterhuis J, Kalscheuer V, Mariman E, Looijenga L. 1994. Biallelic expression of the H19 and IGF2 genes in human testicular germ cell tumors. J Natl Cancer Inst 86:1070-1075.
83. Veltman I, Schepens M, Looijenga L, Strong L, van Kessel A. 2003. Germ cell tumours in neonates and infants: A distinct subgroup? APMIS 111:152-160; discussion 160.
84. Voorhoeve PM, le Sage C, Schrier M, Gillis AJM, Stoop H, Nagel R, Liu Y-P, van Duijse J, Drost J, Griekspoor A, Zlotorynski E, Yabuta N, De Vita G, Nojima H, Looijenga LHJ, Agami R. 2006. A genetic screen implicates miRNA-372 and miRNA-373 As oncogenes in testicular germ cell tumors. Cell 124:1169-1181.